Abstract:Epilepsy is a complex neurological condition characterized by repeated spontaneous seizures and can be induced by initiating seizures known as status epilepticus (SE). Elaborating the critical molecular mechanisms following SE are central to understanding the establishment of chronic seizures. Here, we identify a transient program of molecular and metabolic signaling in the early epileptogenic period, centered on day five following SE in the pre-clinical kainate or pilocarpine models of temporal lobe epilepsy. Our work now elaborates a new molecular mechanism centered around Wnt signaling and a growing network comprised of metabolic reprogramming and mTOR activation. Biochemical, metabolomic, confocal microscopy and mouse genetics experiments all demonstrate coordinated activation of Wnt signaling, predominantly in neurons, and the ensuing induction of an overall aerobic glycolysis (Warburg-like phenomenon) and an altered TCA cycle in early epileptogenesis. A centerpiece of the mechanism is the regulation of pyruvate dehydrogenase (PDH) through its kinase and Wnt target genes PDK4. Intriguingly, PDH is a central gene in certain genetic epilepsies, underscoring the relevance of our elaborated mechanisms. While sharing some features with cancers, the Warburg-like metabolism in early epileptogenesis is uniquely split between neurons and astrocytes to achieve an overall novel metabolic reprogramming. This split Warburg metabolic reprogramming triggers an inhibition of AMPK and subsequent activation of mTOR, which is a signature event of epileptogenesis. Interrogation of the mechanism with the metabolic inhibitor 2-deoxyglucose surprisingly demonstrated that Wnt signaling and the resulting metabolic reprogramming lies upstream of mTOR activation in epileptogenesis. To augment the pre-clinical pilocarpine and kainate models, aspects of the proposed mechanisms were also investigated and correlated in a genetic model of constitutive Wnt signaling (deletion of the transcriptional repressor and Wnt pathway inhibitor HBP1). The results from the HBP1-/- mice provide a genetic evidence that Wnt signaling may set the threshold of acquired seizure susceptibility with a similar molecular framework. Using biochemistry and genetics, this paper outlines a new molecular framework of early epileptogenesis and advances a potential molecular platform for refining therapeutic strategies in attenuating recurrent seizures.

Drinking from the fountain of youth for mTOR-related epilepsy

Mapping The Spatio-Temporal Pattern Of The Mammalian Target Of Rapamycin (Mtor) Activation In Temporal Lobe Epilepsy

Somatic Variants in New Candidate Genes Identified in Focal Cortical Dysplasia Type II

Deletion of mTOR in Reactive Astrocytes Suppresses Chronic Seizures in a Mouse Model of Temporal Lobe Epilepsy

Advances in the mTOR signaling pathway and its inhibitor rapamycin in epilepsy

Anti-seizure gene therapy for focal cortical dysplasia

Senescent cell clearance ameliorates temporal lobe epilepsy and associated spatial memory deficits in mice

Abnormal increased mTOR signaling regulates seizure threshold in Dravet syndrome

Mechanistic target of rapamycin (mTOR) signaling in status epilepticus

Role of the Mtor Signaling Pathway in Epilepsy

Hyperactivity of mTORC1 and mTORC2-dependent signaling mediate epilepsy downstream of somatic PTEN loss

Modeling mTORopathy-related epilepsy in cultured murine hippocampal neurons using the multi-electrode array

Prophylactic senolytic treatment in aged mice reduces seizure severity and improves survival from Status Epilepticus

Targeting the EGFR pathway: An alternative strategy for the treatment of tuberous sclerosis complex?

A Warburg-like metabolic program coordinates Wnt, AMPK, and mTOR signaling pathways in epileptogenesis

Inhibition of Mtor Pathway by Rapamycin Decreases P-glycoprotein Expression and Spontaneous Seizures in Pharmacoresistant Epilepsy

Hyperactivity of mTORC1- and mTORC2-dependent signaling mediates epilepsy downstream of somatic PTEN loss

More is Different in mTORopathies

The clinico-pathological characterisation of focal cortical dysplasia type IIb genetically defined by MTOR mosaicism

A role of dentate gyrus mechanistic target of rapamycin activation in epileptogenesis in a mouse model of posttraumatic epilepsy

Inhibition of Mtorc2 Improves Brain Injury in Epileptic Rats by Promoting Chaperone-Mediated Autophagy